Security key
75943R102
Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY)
CUSIP: 75943R102
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 4,389,099
- Total 13F shares
- 126,697,163
- Share change
- -5,523,095
- Total reported value
- $826,050,230
- Put/Call ratio
- 1059%
- Price per share
- $6.52
- Number of holders
- 171
- Value change
- -$42,426,305
- Number of buys
- 91
- Number of sells
- 78
Report period
Q2 2024
Institutions
171
Top holders
10
RLAY full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Relay Therapeutics, Inc. SEC filings
Relay Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75943R102
Recent filing periods:
Ownership snapshot
Top shareholders of RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with the largest verified stakes, then open the linked filing trail.
Lead holder
SB INVESTMENT ADVISERS (UK) LTD
13D/G signal
—
Evidence rows
50
Latest as of
31 Mar 2024
13F
Lead comparable stake: 636%
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD |
13F
Company
|
636%
|
$231,611,193
27,904,963 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
269%
|
$98,070,053
11,815,669 shares
|
— | 31 Mar 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
223%
|
$81,308,545
9,796,210 shares
|
— | 31 Mar 2024 |
| Casdin Capital, LLC |
13F
Company
|
169%
|
$61,615,664
7,423,574 shares
|
— | 31 Mar 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
157%
|
$57,101,000
6,879,597 shares
|
— | 31 Mar 2024 |
| STATE STREET CORP |
13F
Company
|
137%
|
$49,974,200
6,020,988 shares
|
— | 31 Mar 2024 |
| Bellevue Group AG |
13F
Company
|
135%
|
$49,190,929
5,926,618 shares
|
— | 31 Mar 2024 |
| ArrowMark Colorado Holdings LLC |
13F
Company
|
91%
|
$33,242,911
4,005,170 shares
|
— | 31 Mar 2024 |
| Nextech Invest Ltd. |
13F
Company
|
88%
|
$31,925,195
3,846,409 shares
|
— | 31 Mar 2024 |
| BRAIDWELL LP |
13F
Company
|
85%
|
$31,075,192
3,743,999 shares
|
— | 31 Mar 2024 |
| JPMORGAN CHASE & CO |
13F
Company
|
85%
|
$30,853,325
3,717,268 shares
|
— | 31 Mar 2024 |
| NORGES BANK |
13F
Company
|
77%
|
$28,158,788
3,392,625 shares
|
— | 31 Mar 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
51%
|
$18,402,074
2,216,793 shares
|
— | 31 Mar 2024 |
| Boxer Capital, LLC |
13F
Company
|
41%
|
$15,098,796
1,819,132 shares
|
— | 31 Mar 2024 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
40%
|
$14,634,128
1,763,148 shares
|
— | 31 Mar 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
Company
|
38%
|
$13,905,845
1,675,403 shares
|
— | 31 Mar 2024 |
| DIMENSIONAL FUND ADVISORS LP |
13F
Company
|
36%
|
$13,286,757
1,600,814 shares
|
— | 31 Mar 2024 |
| Alphabet Inc. |
13F
Company
|
36%
|
$13,020,649
1,568,753 shares
|
— | 31 Mar 2024 |
| Finepoint Capital LP |
13F
Company
|
34%
|
$12,368,411
1,490,170 shares
|
— | 31 Mar 2024 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
26%
|
$9,628,971
1,160,117 shares
|
— | 31 Mar 2024 |
| MORGAN STANLEY |
13F
Company
|
26%
|
$9,603,275
1,157,021 shares
|
— | 31 Mar 2024 |
| FMR LLC |
13F
Company
|
25%
|
$9,014,539
1,086,089 shares
|
— | 31 Mar 2024 |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
Company
|
23%
|
$8,297,004
999,639 shares
|
— | 31 Mar 2024 |
| Point72 Asset Management, L.P. |
13F
Company
|
22%
|
$7,901,758
952,019 shares
|
— | 31 Mar 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
Company
|
21%
|
$7,570,903
912,157 shares
|
— | 31 Mar 2024 |
| MPM BioImpact LLC |
13F
Company
|
19%
|
$6,905,741
832,017 shares
|
— | 31 Mar 2024 |
| NORTHERN TRUST CORP |
13F
Company
|
19%
|
$6,875,779
828,407 shares
|
— | 31 Mar 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
17%
|
$6,335,000
763,200 shares
|
— | 31 Mar 2024 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
17%
|
$6,156,135
741,703 shares
|
— | 31 Mar 2024 |
| Integral Health Asset Management, LLC |
13F
Company
|
17%
|
$6,017,500
725,000 shares
|
— | 31 Mar 2024 |
| TWO SIGMA INVESTMENTS, LP |
13F
Company
|
13%
|
$4,877,827
587,690 shares
|
— | 31 Mar 2024 |
| BESSEMER GROUP INC |
13F
Company
|
13%
|
$4,851,000
584,463 shares
|
— | 31 Mar 2024 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
Company
|
13%
|
$4,625,558
557,296 shares
|
— | 31 Mar 2024 |
| ALLIANCEBERNSTEIN L.P. |
13F
Company
|
12%
|
$4,470,405
538,603 shares
|
— | 31 Mar 2024 |
| S.c.a. Candriam |
13F
Individual
|
12%
|
$4,219,961
508,429 shares
|
— | 31 Mar 2024 |
| Rafferty Asset Management, LLC |
13F
Company
|
11%
|
$3,851,698
464,060 shares
|
— | 31 Mar 2024 |
| AMERIPRISE FINANCIAL INC |
13F
Company
|
10%
|
$3,736,428
450,172 shares
|
— | 31 Mar 2024 |
| Prosight Management, LP |
13F
Company
|
10%
|
$3,735,000
450,000 shares
|
— | 31 Mar 2024 |
| CITIGROUP INC |
13F
Company
|
9.5%
|
$3,444,310
414,977 shares
|
— | 31 Mar 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
Company
|
9.1%
|
$3,302,719
397,918 shares
|
— | 31 Mar 2024 |
| TWO SIGMA ADVISERS, LP |
13F
Company
|
9%
|
$3,272,690
394,300 shares
|
— | 31 Mar 2024 |
| PRUDENTIAL FINANCIAL INC |
13F
Company
|
8.3%
|
$3,008,335
362,450 shares
|
— | 31 Mar 2024 |
| TD ASSET MANAGEMENT INC |
13F
Company
|
8.2%
|
$2,976,845
358,656 shares
|
— | 31 Mar 2024 |
| BAILLIE GIFFORD & CO |
13F
Company
|
8%
|
$2,931,776
353,226 shares
|
— | 31 Mar 2024 |
| FEDERATED HERMES, INC. |
13F
Company
|
7.7%
|
$2,792,867
336,490 shares
|
— | 31 Mar 2024 |
| Bank of New York Mellon Corp |
13F
Company
|
7%
|
$2,543,519
306,448 shares
|
— | 31 Mar 2024 |
| ALGERT GLOBAL LLC |
13F
Company
|
6.9%
|
$2,506,000
301,935 shares
|
— | 31 Mar 2024 |
| HARBOURVEST PARTNERS LLC |
13F
Company
|
6.8%
|
$2,460,137
296,402 shares
|
— | 31 Mar 2024 |
| UBS Group AG |
13F
Company
|
6.6%
|
$2,389,786
287,926 shares
|
— | 31 Mar 2024 |
| Woodline Partners LP |
13F
Company
|
6.2%
|
$2,265,966
273,008 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
171
Shares
126,697,163
Rows loaded
172
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
182
Q2 2024 holders
171
Holder diff
-11
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.